Celanese Corporation
CE
$55.32
$0.100.18%
Weiss Ratings | CE - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
Rating | ||||
Reward Index | Weak | |||
Risk Index | Weak | |||
Risk Grade | D | |||
Reward Grade | D+ | |||
Rating Factors | CE - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
Dividend Index | Good | |||
Growth Index | Weak | |||
Efficiency Index | Fair | |||
Solvency Index | Good | |||
Total Return Index | Very Weak | |||
Volatility Index | Weak | |||
Beta / Standard Deviation | CE - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
Beta | 0.99 | |||
Price History | CE - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
7-Day Total Return | 5.07% | |||
30-Day Total Return | -24.92% | |||
60-Day Total Return | -21.53% | |||
90-Day Total Return | -57.11% | |||
Year to Date Total Return | -19.10% | |||
1-Year Total Return | -64.13% | |||
2-Year Total Return | -51.13% | |||
3-Year Total Return | -55.92% | |||
5-Year Total Return | -22.61% | |||
52-Week High % Change | -67.93% | |||
52-Week Low % Change | 20.20% | |||
Price | CE - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
52-Week High Price | $172.16 | |||
52-Week Low Price | $45.94 | |||
52-Week Low Price (Date) | Mar 04, 2025 | |||
52-Week High Price (Date) | Mar 28, 2024 | |||
Valuation | CE - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
Market Cap | 6.04B | |||
Enterprise Value | 18.46B | |||
Price/Earnings (TTM) | -- | |||
Earnings Per Share (TTM) | -13.93 | |||
Earnings Per Share Growth | -177.81% | |||
Price/Earnings To Growth | -- | |||
Price/Sales (TTM) | 0.59 | |||
Price/Book (Q) | 1.17 | |||
Enterprise Value/Revenue (TTM) | 1.80 | |||
Price | $55.32 | |||
Enterprise Value/EBITDA (TTM) | 10.68 | |||
Enterprise Value/EBIT | 18.13 | |||
Market Cap Category | Mid Cap | |||
Dividends and Shares | CE - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
Shares Outstanding | 109.40M | |||
Dividend Yield | 3.86% | |||
Div. Per Share (Most Recent) | $0.03 | |||
Dividend Per Share (TTM) | $2.13 | |||
Payout Ratio (TTM) | -20.17% | |||
Dividend Per Share (Most Recent) | $0.03 | |||
Company Info | CE - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
Phone Number | 972 443 4000 | |||
Address | 222 W. Las Colinas Blvd. Irving, TX 75039-5421 | |||
Website | www.celanese.com | |||
Country | United States | |||
Year Founded | 1912 | |||
Profitability | CE - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
Operating Margin (TTM) | 9.90% | |||
Profit Margin | -14.80% | |||
Management Effectiveness | CE - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
Return on Assets | 2.57% | |||
Return on Equity | -- | |||
Income Statement | CE - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
Revenue (TTM) | 10.28B | |||
Total Revenue (TTM) | 10.28B | |||
Revenue Per Share | $93.97 | |||
Gross Profit (TTM) | 2.36B | |||
EBITDA (TTM) | 1.73B | |||
EBIT (TTM) | 1.02B | |||
Net Income (TTM) | -1.52B | |||
Net Income Avl. to Common (TTM) | -1.52B | |||
Total Revenue Growth (Q YOY) | -7.75% | |||
Earnings Growth (Q YOY) | -369.59% | |||
EPS Diluted (TTM) | -13.93 | |||
EPS Diluted Growth (Q YOY) | -374.67% | |||
Balance Sheet | CE - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
Cash and Short-Term Inv. (Q) | 962.00M | |||
Cash Per Share (Q) | $8.79 | |||
Total Current Assets (Q) | 5.15B | |||
Total Preferred Equity (Q) | -- | |||
Total Equity (Q) | 5.61B | |||
Current Ratio (Q) | 1.335 | |||
Book Value Per Share (Q) | $47.33 | |||
Total Assets (Q) | 22.86B | |||
Total Current Liabilities (Q) | 3.85B | |||
Total Debt (Q) | 12.95B | |||
Total Liabilities (Q) | 17.25B | |||
Total Common Equity (Q) | 5.18B | |||
Cash Flow | CE - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
Cash from Investing (TTM) | -470.00M | |||
Cash from Financing (TTM) | -1.31B | |||
Net Change in Cash (TTM) | -843.00M | |||
Levered Free Cash Flow (TTM) | 452.75M | |||
Cash from Operations (TTM) | 966.00M | |||